17:29:04 EST Tue 25 Feb 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Bioneutra Global Corp
Symbol BGA
Shares Issued 45,819,787
Close 2020-01-14 C$ 0.40
Recent Sedar Documents

ORIGINAL: Bioneutra appoints Cretney CFO to replace Alanen

2020-01-14 23:42 ET - News Release

Received by email:

File: '\\doc\emailin\20200114 194415 Attachment Final draft press release announcing new CFO (E8467697).docx'


  
BIONEUTRA GLOBAL CORPORATION 
ANNOUNCES CHANGE OF CHIEF FINANCIAL OFFICER
  

Edmonton, Alberta - (January 14th, 2020) - BioNeutra Global Corporation ("BioNeutra" or the "Company") (TSXV: BGA), is p
--->leased to announce that Mr. Chad Cretney, CPA, has been appointed as the Chief Financial Officer of the Company, effecti
--->ve immediately.

Mr. Cretney has more than 25 years of experience in financing and operations management.  Prior to this, Mr. Cretney hel
--->d the positions of Chief Financial Officer and Controller respectively of two separate private Alberta corporations, and
---> as well, he had previously been the Vice President of Advisory Services for one of the "Large Four" accounting firms in
---> Calgary, Alberta.

Mr. Cretney replaces Mr. Scott Alanen who has tendered his resignation as the Chief Financial Officer, effective today.

About BioNeutra

BioNeutra is in the business of research and development, production and commercialization of ingredients for nutraceuti
--->cal, functional and mainstream foods and beverages, with a focus on VitaFiber(TM) IMOs.  

The Company's lead product, VitaFiber(TM), is an advanced functional and health food and beverage ingredient scientifica
--->lly made from natural agricultural products, is generally regarded as safe (GRAS) by the U.S. Food & Drug Administration
--->, and is European Food Safety Authority and Health Canada approved as a novel food ingredient.  VitaFiber(TM) is natural
--->ly sweet and lower in calories than regular sugar and is a natural source of dietary fiber as it provides low calorie so
--->luble prebiotic fiber for human digestive health. 

The Company produces VitaFiber(TM) using its patented processes that naturally transform starch molecules from agricultu
--->re cereal crops including Non-GMO corn, wheat, barley, potato, or tapioca into the functional health molecules of VitaFi
--->ber(TM) IMO.  The VitaFiber(TM) manufacturing process is based upon a natural enzymatic conversion of starch molecules w
--->ithout any chemical modification involved, making VitaFiber(TM) a natural food and beverage ingredient.  VitaFiber(TM) i
--->s also non-GMO, vegan-friendly, gluten-free, Kosher and Halal certified and available as certified organic.

The Company's customers include a mix of small and medium enterprises and a number of high-profile food and beverage man
--->ufacturers in Canada, the U.S., Europe, the United Kingdom, and Mexico. VitaFiber(TM) is also available for retail purch
--->ase across the globe through Amazon.com and other direct-to-consumer retailers.  

Further information about BioNeutra is available on the Company's website at www.bioneutra.ca and the SEDAR website at w
--->ww.sedar.com.  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TS
--->X Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
 
For further information on BioNeutra, please contact:

Dr. Jianhua Zhu
President and Chief Executive Officer
Tel: (780) 466-1481 (Ext. 132)
Email: jianhua.zhu@bioneutra.ca


Forward-Looking Information
This press release may include forward-looking information within the meaning of Canadian securities legislation concern
--->ing the business of BioNeutra.  Forward-looking information is based on certain key expectations and assumptions made by
---> the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-lo
--->oking information is based are reasonable, undue reliance should not be placed on the forward-looking information becaus
--->e BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press
---> release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly 
--->any forward-looking information, whether as a result of new information, future events or results or otherwise, other th
--->an as required by applicable securities laws. 
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities descri
--->bed herein in the United States. The securities described herein have not been and will not be registered under the Unit
--->ed States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and ma
--->y not be offered or sold in the United States or to the account or benefit of a person in the United States absent an ex
--->emption from the registration requirements.



© 2020 Canjex Publishing Ltd. All rights reserved.